Nov52025 Unlocking Community-Based Trials: Major Takeaways from the Inaugural RxE2 Un-Conference MORE
Nov42025 Engineering the Future of Community-Based Trials: How RxE2 is Bringing Clinical Research to the Community Pharmacy MORE
Oct282025 Celebrating Trust and Innovation: Closing American Pharmacists Month with Teresa Gerbig, PharmD MORE
Oct12025 Celebrating American Pharmacists Month: Featuring Tina Schlecht, PharmD, Chief Pharmacy Officer, RxE2 MORE
Aug122025 Redefining Community Pharmacy: An Interview with Dr. Anthony Bolus, Clinical Coordinator at Family Medical Services MORE
May262025 Driving Innovation and Patient Care: A Conversation with Pharmacist Jenna Eccles of Wheat Ridge Professional Pharmacy MORE
Nov242024 The Evolving Role of the Community Pharmacist: An Opportunity to Bring the Study to the Patient MORE
Apr212024 RxE2 Direct-to-Patient IP Dispensing for a Dose-Ranging Phase 1/2 Decentralized Clinical Trial MORE
Jan292024 Enhancing Patient Recruitment through Community Pharmacies for a Phase 2 Neurological Study MORE
Dec42023 RxE2 Revolutionizes Clinical Trials with Groundbreaking AI-led Technology Platform and Marketplace MORE
Sep172022 Moving the Needle: How the Practice of Pharmacy Addresses Key Issues in Clinical Research MORE
Sep62022 RxE2 Founder and CEO Gerald Finken on the Role and Value of Pharmacists in Clinical Research MORE
Apr202021 The Impact of Decentralized Clinical Trials on the Investigational Drug Supply Chain: Making Clinical Supplies Patient-Centric MORE
Feb22021 RxE2 CEO and Two-Time USA Cycling Masters Nationals Champion Gerald Finken Donates $27,500 to NorthStar Development Cycling Club MORE
Jan112021 RxE2 Agrees to Acquire Habitu to Form the First AI Driven, Pharmacist-Led, Clinical Trial Platform MORE
Aug32020 RxE2 and Newdays Pharmacy Expand E2 Dispensing Service for Clinical Drug Trials to the EU and UK MORE
Jul132020 RxE2 and Thrifty White Pharmacy Establish First E2 Dispensing Service for Clinical Drug Trials in the US MORE
